Anti-Asthma TDM Assay Kits Market Segmentation:
The global anti-asthma TDM assay kits market is segmented and analyzed for demand and supply by product type into ELISA assay kits, immunoassay kits, and others. Out of the three types of products, the ELISA assay kits segment is estimated to gain the largest market share over the projected time frame. The enzyme-linked immunosorbent assay, or ELISA test, quantifies the quantity of allergen-specific antibodies in our body. The growth of the segment can be attributed to the rise in the number of variants of ELISA test kits manufactured in the market. For instance, a leading manufacturer of China, Wuhan Fine Biotech Co., Ltd. currently have more than 7600 types of ELISA kits in the market.
The global anti-asthma TDM assay kits market is also segmented and analyzed for demand and supply by end-user in hospitals, diagnostic laboratories, research centers & academic institutes. Amongst these three segments, the hospital segment is expected to garner a significant share. Patients suffering from asthma often visit hospitals for treatment, and Acute asthma attacks continue to be a common reason for ER visits and hospital admissions. In 2018, around 6 million asthma patients visited hospitals for treatment. Moreover, in the same year, around 180,000 people were discharged from hospital inpatient care and nearly 2 million asthmatic patients were released from the hospital's emergency department. Furthermore, asthma-related visits to the emergency room are approximately five times as common among black Americans than among white Americans.
Our in-depth analysis of the global anti-asthma TDM assay kits market includes the following segments:
|
By Product Type |
|
|
By Assay Type |
|
|
By End User |
|
